Drugs / Chondroitin sulfate
Trials 16 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 12 trials | ||||||
| Phase 1 | NCT06547424 | Jan 2025 → Dec 2028 | ischemic bowel disorder, necrotizing enterocolitis | Indiana University | Withdrawn | No outcome recorded |
| Phase 1 | NCT03697876 | Aug 2018 → Jun 2024 | dry eye syndrome | Laboratorios Sophia S.A de C.V. | Completed | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01245088 | Jan 2011 → Mar 2012 | Crohn disease | University Hospitals Cleveland Medical Center | Withdrawn | No outcome recorded |
| Phase 36 trials | ||||||
| Phase 3 | NCT02079727 | Jun 2014 → Oct 2015 | osteoarthritis, knee | IBSA Institut Biochimique SA | Completed | No outcome recorded |
| Phase 3 | NCT01893905 | Jun 2013 → Aug 2014 | osteoarthritis, knee | Tedec-Meiji Farma, S.A. | Completed | No outcome recorded |
| Phase 3 | NCT01293305 | Nov 2011 → Aug 2012 | osteoarthritis | Azidus Brasil | Unknown | No outcome recorded |
| Phase 3 | NCT01354145 | Jun 2011 → Sep 2014 | osteoarthritis, knee | Bioiberica | Completed | No outcome recorded |
| Phase 3 | NCT02010918 | Feb 2009 → Nov 2010 | osteoarthritis, knee | Ache Laboratorios Farmaceuticos S.A. | Completed | No outcome recorded |
| Phase 3 | NCT00032890 | Apr 2000 → Feb 2004 | osteoarthritis | US Department of Veterans Affairs | Completed | No outcome recorded |
| Phase 46 trials | ||||||
| Phase 4 | NCT04702776 | Dec 2021 → May 2023 | dry eye syndrome | Laboratorios Sophia S.A de C.V. | Completed | No outcome recorded |
| Phase 4 | NCT02823548 | Aug 2016 → Jun 2017 | osteoarthritis, hand | Bioiberica | Unknown | No outcome recorded |
| Phase 4 | NCT02821468 | Jun 2016 → Dec 2017 | osteoarthritis, knee | Bioiberica | Unknown | No outcome recorded |
| Phase 4 | NCT01425853 | Sep 2011 → Apr 2013 | osteoarthritis, knee | Bioiberica | Completed | No outcome recorded |
| Phase 4 | NCT01233739 | Mar 2011 → Apr 2013 | arthropathy, erosive | Juan A. Arnaiz | Unknown | No outcome recorded |
| Phase 4 | NCT00294801 | Jan 2006 → Dec 2007 | osteoarthritis | Rabin Medical Center | Unknown | No outcome recorded |
| Phase not applicable1 trial | ||||||
| — | NCT03463499 | Sep 2017 → Sep 2019 | interstitial cystitis | Samsung Medical Center | Completed | No outcome recorded |
Also used as a comparator or background therapy in 6 trials
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 21 trial | ||||||
| Phase 2 | NCT05429229 Comparator | Nov 2021 → Dec 2023 | diabetic retinopathy, disorder of defective peroxisome oxidative status, dry eye syndrome | Adolfo Daniel Rodriguez-Carrizalez | Unknown | No outcome recorded |
| Phase 32 trials | ||||||
| Phase 3 | NCT02830919 Comparator | Dec 2016 → May 2019 | osteoarthritis, knee | Eurofarma Laboratorios S.A. | Completed | No outcome recorded |
| Phase 3 | NCT01172249 Comparator | — | osteoarthritis, knee | Mantecorp Industria Quimica e Farmaceutica Ltd. | Unknown | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT00805519 Comparator | Feb 2009 → Apr 2010 | osteoarthritis, knee | Ardabil University of Medical Sciences | Completed | No outcome recorded |
| Phase not applicable2 trials | ||||||
| — | NCT05223946 Background | Sep 2020 → May 2021 | — | Kyrgyz State Medical Academy | Completed | No outcome recorded |
| — | NCT05385562 Comparator | Jan 2020 → May 2022 | macular retinal edema | Al-Azhar University | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 22 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Chondroitin sulfate | “It consists of eye drops without preservatives composed of 0.1% sodium hyaluronate and 0.18% chondroitin sulfate, one drop is applied to each eye every 4 hours for a month.” NCT05429229 ↗21“ketoprofen, tolperisone, symptomatic slow-acting drugs in osteoarthritis - SYSADOA - (glucosamine + chondroitin sulfate )” NCT05223946 ↗ “Active ingredients: Chondroitin sulfate, 200 mg and Glucosamine hydrochloride 250 mg.” NCT01425853 ↗ “PRO-165 Chondroitin sulfate 0.18% / sodium hyaluronate 0.2%, ophthalmic gel.” NCT03697876 ↗ “Combined Chondroitin Sulfate 1200 mg + Glucosamine Hydrochloride 1500 mg” NCT02821468 ↗ “Chondroitin Sulfate 1,200mg + Glucosamine Hydrochloride 1,500mg” NCT02823548 ↗ “chondroitin sulfate (CS) and glucosamine sulfate (GS)” PMID 27477804 ↗ Jan 2017 “containing glucosamine an chondroitin sulfate” NCT00294801 ↗ |
| Known as | Chondroitin 4&6 sulfate | “800 mg Chondroitin 4&6 sulfate (Condrosulf) vs placebo once a day for 6 months” NCT02079727 ↗ |
| Route | Oral | “one capsule T.I.D. before meals” NCT01172249 ↗ |